Transgene Reports Results From Clinical Study of TG4001 in Combination With Avelumab in Advanced HPV-Positive Cancers
Go back to Transgene Reports Results From Clinical Study of TG4001 in Combination With Avelumab in Advanced HPV-Positive Cancers| Pfizer Inc. (NYSE: PFE) | Delayed: 28.45 -0.36 (1.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.81 | 52 Week High | $37.39 | |||
| Open | $28.58 | 52 Week Low | $28.25 | |||
| Day High | $28.69 | P/E | 17.24 | |||
| Day Low | $28.38 | EPS | $1.65 | |||
| Volume | 23,790,788 | |||||
| Puritan Financial Group, Inc. (AMEX: TNG) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $0.01 | |||
| Open | $0.01 | 52 Week Low | $0.01 | |||
| Day High | $0.01 | P/E | N/A | |||
| Day Low | $0.01 | EPS | $0.00 | |||
| Volume | 0 | |||||
